Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1998-1-28
pubmed:abstractText
To evaluate the ocular hypotensive response of latanoprost 0.005% administered as adjunctive therapy in patients with glaucoma who were receiving maximal tolerated medical therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0002-9394
pubmed:author
pubmed:issnType
Print
pubmed:volume
124
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
279-86
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9439353-Adolescent, pubmed-meshheading:9439353-Adult, pubmed-meshheading:9439353-Aged, pubmed-meshheading:9439353-Aged, 80 and over, pubmed-meshheading:9439353-Chemotherapy, Adjuvant, pubmed-meshheading:9439353-Child, pubmed-meshheading:9439353-Clinical Protocols, pubmed-meshheading:9439353-Drug Hypersensitivity, pubmed-meshheading:9439353-Drug Synergism, pubmed-meshheading:9439353-Female, pubmed-meshheading:9439353-Glaucoma, pubmed-meshheading:9439353-Humans, pubmed-meshheading:9439353-Intraocular Pressure, pubmed-meshheading:9439353-Male, pubmed-meshheading:9439353-Middle Aged, pubmed-meshheading:9439353-Ophthalmic Solutions, pubmed-meshheading:9439353-Prospective Studies, pubmed-meshheading:9439353-Prostaglandins F, Synthetic, pubmed-meshheading:9439353-Treatment Outcome
pubmed:year
1997
pubmed:articleTitle
Latanoprost for uncontrolled glaucoma in a compassionate case protocol.
pubmed:affiliation
Department of Ophthalmology, New York Eye and Ear Infirmary, New York 10003, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study